Main Menu

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Find out about how philanthropy supports our research, learn about our Enterprise Unit and read news on gene-targeted medicine.

Back to top
  • Cancer research offers more hope than people think

    Cancer research offers more hope than people think

    The strong public focus on a ‘cure for cancer’ is masking dramatic progress in extending the lives of patients with advanced cancer and turning it into a manageable disease long term, a YouGov poll of members of the public and cancer patients has found.

    Read more
  • Scientific achievements 2019

    Scientific achievements 2019

    We've selected a range of discoveries from 2018/19 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.

    Read more
  • New test predicts chance of living more than a year on targeted breast cancer treatment

    New test predicts chance of living more than a year on targeted breast cancer treatment

    A new test could pick out women with advanced breast cancer who are likely to benefit from an exciting new targeted therapy for more than a year.

    Read more
  • Let’s finish it: Centre for Cancer Drug Discovery Appeal

    Let’s finish it: Centre for Cancer Drug Discovery Appeal

    We are creating a new state-of-the art drug discovery centre to create more and better drugs for cancer patients. The centre is a £75m build – and we now have less than £14m to raise. To make our building a reality, we urgently need your philanthropic support.

    Support us
  • Olaparib becomes first gene-targeted medicine to show benefits in prostate cancer

    Olaparib becomes first gene-targeted medicine to show benefits in prostate cancer

    A pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer, a new clinical trial shows.

    Read more
  • Carols from Chelsea 2019: Festive season begins in style with carol service for cancer research

    Carols from Chelsea 2019: Festive season begins in style with carol service for cancer research

    Familiar faces and voices from stage and screen came together on Tuesday 3 December to celebrate the start of the Christmas season at the 17th annual Carols from Chelsea service in support of The ICR.

    Read more
1/6

Philanthropy

Philanthropy has played a key role in the progress we have made over the years and there are many opportunities to play a part in the future of cancer research.

Find out more

Share your story

We always want to hear from people who have a cancer story to share. Get in touch and help raise awareness of our research.

Find out more

Centre for Cancer Drug Discovery

We are building a new state-of-the art drug discovery centre to create more and better drugs for cancer patients. To make our building a reality, we urgently need your philanthropic support.

Find out more

How we work with industry

We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.

Find out more

Our scientific discoveries

For more than 100 years, the ICR has played an important role in shaping understanding of cancer and how it can be treated.

Find out more

The Drug Discoverer

Our Chief Executive and President, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.

Find out more